COMMUNIQUÉS West-GlobeNewswire

AnaptysBio Reports Positive Topline Data from Interim Analysis of GALLOP Phase 2 Clinical Trial of ANB019 Monotherapy in Moderate-to-Severe Generalized Pustular Psoriasis

30/09/2019 - 22:15

Interim analysis conducted with first two patients to complete 16-week (Day 113) ANB019 monotherapy study Both patients achieved the primary endpoint of disease score improvement at Day 29 and Day 113 without requiring [...]

Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30/09/2019 - 22:07

HOUSTON, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Aduro Biotech to Present at the 2019 Cantor Global Healthcare Conference

30/09/2019 - 22:05

BERKELEY, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Andrea van Elsas, chief scientific officer of Aduro, is scheduled to present at the 2019 Cantor Global [...]

Ocugen to Present at Three Upcoming Conferences

30/09/2019 - 22:05

MALVERN, Pa., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Ocugen, Inc. , (NASDAQ: OCGN) a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that [...]

Dynavax to Present at the 2019 Cantor Global Healthcare Conference

30/09/2019 - 22:05

BERKELEY, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), today announced that Ryan Spencer, Senior Vice President, Commercial, and Interim Co-President, will present at the [...]

Predictive Technology Group Reports Fiscal Year 2019 Financial Results

30/09/2019 - 22:02

Revenue increases 162% to $43.5 million with $3.5 million in positive cash flow from operations SALT LAKE CITY, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED) (the Company), a [...]

Celldex Therapeutics to Present at the Cantor Global Healthcare Conference

30/09/2019 - 22:01

HAMPTON, N.J., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Anthony Marucci, Co-founder, President and Chief Executive Officer, and Tibor Keler, PhD, Cofounder, [...]

Inventiva completes a capital increase of € 625,000 subscribed by Sofinnova Partners through Sofinnova Crossover I Fund

30/09/2019 - 20:35

Daix (France), September 30 th , 2019 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas of fibrosis, lysosomal [...]

Inventiva réalise une augmentation de capital de 625.000 euros souscrite par Sofinnova Partners, au travers de son fonds Sofinnova Crossover I Fund

30/09/2019 - 20:35

Daix (France), le 30 septembre 2019 – Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de maladies dans [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2019

30/09/2019 - 20:33

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2019 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]

AB Science today reports its revenues for the first half of 2019 and provides an update on its activities.

30/09/2019 - 19:41

Paris, September 30, 2019, 8pm Net loss of 13M€ in the first half of 2019 Operating loss of -10.6M€, a 25.5% expenses decrease as compared with the first half of 2018 (14.2M€) Cash position of 2.7M€ as of 30 June 2019, [...]

AB Science annonce aujourd’hui ses résultats financiers semestriels au 30 juin 2019 et présente un point sur ses activités

30/09/2019 - 19:41

Paris, 30 septembre 2019, 20h Perte nette de 13M€ au premier semestre 2019 Déficit opérationnel de 10,6 M€, soit une réduction des dépenses de 25,5% par rapport au premier semestre 2018 (14,2M€) Trésorerie de 2,7M€ au [...]

Predictive Oncology Inc. Announces Repayment or Extension of Promissory Notes due September 28, 2019

30/09/2019 - 19:00

MINNEAPOLIS, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive” or “the Company”) today announced that its secured promissory notes that were due September 28, 2019 have been repaid [...]

Assertio Therapeutics Announces Appointment of Dr. David Wheadon to its Board of Directors

30/09/2019 - 18:35

LAKE FOREST, Ill., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Dr. David Wheadon has been appointed to the Company’s Board of Directors. Dr. Wheadon is a former [...]

Theratechnologies to Present at Cantor Fitzgerald Global Healthcare Conference in New York City

30/09/2019 - 18:18

MONTREAL, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer will make a presentation at [...]

Le chef de la direction financière assistera au Cantor Fitzgerald Global Healthcare Conference à New York

30/09/2019 - 18:18

MONTRÉAL, 30 sept. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que Philippe Dubuc, vice-président senior et chef de la direction financière, fera une [...]

Cronos Group Announces Appointment of Jody Begley to Board of Directors

30/09/2019 - 18:01

TORONTO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that, in connection with its investment in the Company, Altria Group, Inc. (“ [...]

Molina Healthcare Announces Third Quarter 2019 Earnings Release and Conference Call Dates

30/09/2019 - 18:00

Long Beach, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the third quarter ended September 30, 2019. Molina Healthcare will [...]

CV Sciences Applauds House Passage of the SAFE Banking Act of 2019

30/09/2019 - 17:59

The SAFE Banking Act Provides the Cannabis Industry Access to Banking and Financial Services SAN DIEGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we [...]